There is no scientific evidence that ovulation induction treatment leads to possible long-term secondary effects to the woman health.
There are two major short-term risks associated with ovulation induction treatment. The most common is multiple pregnancies (between 15 and 20%); the least common is over-stimulation or ovarian hyperstimulation (1%).
The monitoring of the number and size of the follicles and of the estradiol levels during ovulation helps to identify cycles with a greater risk of hyperstimulation and multiple pregnancies and cycles which should be cancelled, evaluating each case individually.
Once a pregnancy is achieved, the possible risks for the mother or foetus are the same as those occurring with a spontaneous pregnancy, except in the case of complications occurring due to possible multiple pregnancies, such as prematurity and low birth weight.